Siah: A promising anticancer target

Cancer Research

Volumn 73, Issue 8, 2013, Pages 2400-2406

  Wong, Christina S F ^a   Moller, Andreas ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MENADIONE; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE SIAH; UBIQUITIN PROTEIN LIGASE SIAH 1; UBIQUITIN PROTEIN LIGASE SIAH 2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CANCER RESEARCH; CANCER SURVIVAL; CARCINOGENESIS; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; HUMAN; LUNG CANCER; MELANOMA; NONHUMAN; ONCOGENE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84876986498     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-4348     Document Type: Review

References (41)

1. Lakshmanan M, Bughani U, Duraisamy S, Diwan M, Dastidar S, Ray A. Molecular targeting of E3 ligases-a therapeutic approach for cancer. Expert Opin Ther Targets 2008;12:855-70.
2. Lipkowitz S, Weissman AM. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev 2011;11:629-43.
3. Holloway AJ, Della NG, Fletcher CF, Largespada DA, Copeland NG, Jenkins NA, et al. Chromosomal mapping of five highly conserved murine homologues of the Drosophila RING finger gene seven-inabsentia. Genomics 1997;41:160-8.
4. Habelhah H, Frew IJ, Laine A, Janes PW, Relaix F, Sassoon D, et al. Stress-induced decrease in TRAF2 stability is mediated by Siah2. EMBO J 2002;21:5756-65.
5. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, et al. Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 2001;7: 927-36.
6. House CM, Hancock NC, Moller A, Cromer BA, Fedorov V, Bowtell DD, et al. Elucidation of the substrate binding site of Siah ubiquitin ligase. Structure 2006;14:695-701.
7. House CM, Frew IJ, Huang HL, Wiche G, Traficante N, Nice E, et al. A binding motif for Siah ubiquitin ligase. Proc Natl Acad Sci U S A 2003;100:3101-6.
8. House CM, Moller A, Bowtell DD. Siah proteins: Novel drug targets in the Ras and hypoxia pathways. Cancer Res 2009;69:8835-8.
9. Nakayama K, Qi J, Ronai Z. The ubiquitin ligase Siah2 and the hypoxia response. Mol Cancer Res 2009;7:443-51.
10. Khurana A, Nakayama K, Williams S, Davis RJ, Mustelin T, Ronai Z. Regulation of the ring finger E3 ligase Siah2 by p38 MAPK. J Biol Chem 2006;281:35316-26.
11. Scortegagna M, Subtil T, Qi J, Kim H, Zhao W, Gu W, et al. USP13 enzyme regulates Siah2 ligase stability and activity via noncatalytic ubiquitin-binding domains. J Biol Chem 2011;286:27333-41.
12. Frasor J, Danes JM, Funk CC, Katzenellenbogen BS. Estrogen downregulation of the corepressor N-CoR: Mechanism and implications for estrogen derepression of N-CoR-regulated genes. Proc Natl Acad Sci U S A 2005;102:13153-7.
13. Schmidt RL, Park CH, Ahmed AU, Gundelach JH, Reed NR, Cheng S, et al. Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue. Cancer Res 2007;67:11798-810.
14. Ahmed AU, Schmidt RL, Park CH, Reed NR, Hesse SE, Thomas CF, et al. Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth. J Natl Cancer Inst 2008;100:1606-29.
15. Qi J, Nakayama K, Gaitonde S, Goydos JS, Krajewski S, Eroshkin A, et al. The ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and-independent pathways. Proc Natl Acad Sci U S A 2008;105:16713-8.
16. Möller A, House CM, Wong CS, Scanlon DB, Liu MC, Ronai Z, et al. Inhibition of Siah ubiquitin ligase function. Oncogene 2009;28: 289-96.
17. Qi J, Nakayama K, Cardiff RD, Borowsky AD, Kaul K, Williams R, et al. Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell 2010;18:23-38.
18. Wong CS, Sceneay J, House CM, Halse HM, Liu MC, George J, et al. Vascular normalization by loss of Siah2 results in increased chemotherapeutic efficacy. Cancer Res 2012;72:1694-704.
19. Chan P, Moller A, Liu MC, Sceneay JE, Wong CS, Waddell N, et al. The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression. Breast Cancer Res 2011;13:R19.
20. Behling KC, Tang A, Freydin B, Chervoneva I, Kadakia S, Schwartz GF, et al. Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma. Breast Cancer Res Treat 2011;29:717-24.
21. Brauckhoff A, Malz M, Tschaharganeh D, Malek N, Weber A, Riener MO, et al. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells. J Hepatol 2011;55:1049-57.
22. Malz M, Aulmann A, Samarin J, Bissinger M, Longerich T, Schmitt S, et al. Nuclear accumulation of seven in absentia homologue-2 supports motility and proliferation of liver cancer cells. Int J Cancer 2012;131:2016-26.
23. Confalonieri S, Quarto M, Goisis G, Nuciforo P, Donzelli M, Jodice G, et al. Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor. Oncogene 2009;28:2959-68.
24. Bruzzoni-Giovanelli H, Fernandez P, Veiga L, Podgorniak MP, Powell DJ, Candeias MM, et al. Distinct expression patterns of the E3 ligase SIAH-1 and its partner Kid/KIF22 in normal tissues and in the breast tumoral processes. J Exp Clin Cancer Res 2010;29:10.
25. Yoshibayashi H, Okabe H, Satoh S, Hida K, Kawashima K, Hamasu S, et al. SIAH1 causes growth arrest and apoptosis in hepatoma cells through beta-catenin degradation-dependent and-independent mechanisms. Oncol Rep 2007;17:549-56.
26. Kim CJ, Cho YG, Park CH, Jeong SW, Nam SW, Kim SY, et al. Inactivating mutations of the Siah-1 gene in gastric cancer. Oncogene 2004;23:8591-6.
27. Kramer OH, Stauber RH, Bug G, Hartkamp J, Knauer SK. SIAH proteins: Critical roles in leukemogenesis. Leukemia. 2012 Oct 5. [Epub ahead of print].
28. Roperch JP, Lethrone F, Prieur S, Piouffre L, Israeli D, Tuynder M, et al. SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: Identification of common effectors with p53 and p21(Waf1). Proc Natl Acad Sci U S A 1999;96:8070-3.
29. TuynderM,SusiniL,PrieurS,BesseS,FiucciG,AmsonR,et al. Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1. Proc Natl Acad Sci U S A 2002;99:14976-81.
30. Telerman A, Amson R. The molecular programme of tumour reversion: The steps beyond malignant transformation. Nat Rev 2009;9:206-16.
31. Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J, et al. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol 2008;10:812-24.
32. Medhioub M, Vaury C,Hamelin R, Thomas G. Lack of somatic mutation in the coding sequence of SIAH1 in tumors hemizygous for this candidate tumor suppressor gene. Int J Cancer 2000;87:794-7.
33. Hu G, Fearon ER. Siah-1 N-terminal RING domain is required for proteolysis function, and C-terminal sequences regulate oligomerization and binding to target proteins. Mol Cell Biol 1999;19:724-32.
34. Polekhina G, House CM, Traficante N, Mackay JP, Relaix F, Sassoon DA, et al. Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-alpha signaling. Nat Struct Biol 2002;9:68-75.
35. Della NG, Senior PV, Bowtell DD. Isolation and characterisation of murine homologues of the Drosophila seven in absentia gene (sina). Development 1993;117:1333-43.
36. Crone J, Glas C, Schultheiss K, Moehlenbrink J, Krieghoff-Henning E, Hofmann TG. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis. Cancer Res 2011;71:2350-9.
37. Shah M, Stebbins JL, Dewing A, Qi J, Pellecchia M, Ronai ZA. Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis. Pigment Cell Melanoma Res 2009;22:799-808.
38. Brauckhoff A, Ehemann V, Schirmacher P, Breuhahn K. Reduced expression of the E3-ubiquitin ligase seven in absentia homologue (SIAH)-1 in human hepatocellular carcinoma. Verh Dtsch Ges Pathol 2007;91:269-77.
39. He HT, Fokas E, You A, Engenhart-Cabillic R, An HX. Siah1 proteins enhance radiosensitivity of human breast cancer cells. BMC Cancer 2010;10:403.
40. Wen YY, Yang ZQ, Song M, Li BL, Yao XH, Chen XL, et al. The expression of SIAH1 is downregulated and associated with Bim and apoptosis in human breast cancer tissues and cells. Mol Carcinog 2010;49:440-9.
41. Wen YY, Yang ZQ, Song M, Li BL, Zhu JJ, Wang EH. SIAH1 induced apoptosis by activation of the JNK pathway and inhibited invasion by inactivation of the ERK pathway in breast cancer cells. Cancer Sci 2010;101:73-9.